Collaboration Details

Title of Collaborative Activity:

Interferon Lambda (IFN-?): Disease Impact and Therapeutic Potential

Description of Collaborative Activity:

Scientists from the National Cancer Institute (NCI) and Food and Drug Administration (FDA) collaborated to organize a meeting that was held at the National Institutes of Health (NIH) on October 25-26, 2018. The purpose of the meeting was to promote research on IFN-λs by enhancing interdisciplinary communication.

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:

2017

NIH Participating Institutes/Centers/Office of the Director:

NCI, NIAID, NIDDK

HHS Agency Collaborators on this Activity:

FDA